Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine

Go back to Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Pfizer Inc. (NYSE: PFE) Delayed: 25.06 -0.15 (0.6%)
Previous Close $25.21    52 Week High $37.39 
Open $25.22    52 Week Low $28.25 
Day High $25.31    P/E 15.19 
Day Low $24.96    EPS $1.65 
Volume 9,031,532       

Pfizer Inc. (NYSE: PFE) Delayed: 25.06 -0.15 (0.6%)
Previous Close $25.21    52 Week High $37.39 
Open $25.22    52 Week Low $28.25 
Day High $25.31    P/E 15.19 
Day Low $24.96    EPS $1.65 
Volume 9,031,532